Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Wersinger

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The European Journal of Neuroscience|December 13, 2006
Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synucleinChristophe Wersinger, Alexis Jeannotte, Anita Sidhu
Neuroscience Letters|May 24, 2015
Transcriptional regulation of the α-synuclein gene in human brain tissueSteffen Brenner, Christophe Wersinger, Thomas Gasser
FEBS Letters|May 12, 2004
alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's diseaseAnita Sidhu, Christophe Wersinger, Philippe Vernier
Biochemistry|February 6, 2004
Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutantChristophe Wersinger, Philippe Vernier, Anita Sidhu
Molecular and Cellular Neurosciences|February 14, 2004
Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidationChristophe Wersinger, Jun Chen, Anita Sidhu
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stressChristophe Wersinger, Delphine Prou, Philippe Vernier, et al.
Biochemistry|May 5, 2004
Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamineCharbel E-H Moussa, Christophe Wersinger, York Tomita, et al.
Annals of the New York Academy of Sciences|February 1, 2005
The role of alpha-synuclein in both neuroprotection and neurodegenerationAnita Sidhu, Christophe Wersinger, Charbel E-H Moussa, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|June 12, 2003
Diminished expression of constitutive nitric oxide synthases in the kidney of spontaneously hypertensive ratUjendra Kumar, Yangmee Shin, Christophe Wersinger, et al.
Molecular and Cellular Neurosciences|October 11, 2003
Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activityChristophe Wersinger, Delphine Prou, Philippe Vernier, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The European Journal of Neuroscience|December 13, 2006
Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synucleinChristophe Wersinger, Alexis Jeannotte, Anita Sidhu
Neuroscience Letters|May 24, 2015
Transcriptional regulation of the α-synuclein gene in human brain tissueSteffen Brenner, Christophe Wersinger, Thomas Gasser
FEBS Letters|May 12, 2004
alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's diseaseAnita Sidhu, Christophe Wersinger, Philippe Vernier
Biochemistry|February 6, 2004
Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutantChristophe Wersinger, Philippe Vernier, Anita Sidhu
Molecular and Cellular Neurosciences|February 14, 2004
Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidationChristophe Wersinger, Jun Chen, Anita Sidhu
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stressChristophe Wersinger, Delphine Prou, Philippe Vernier, et al.
Biochemistry|May 5, 2004
Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamineCharbel E-H Moussa, Christophe Wersinger, York Tomita, et al.
Annals of the New York Academy of Sciences|February 1, 2005
The role of alpha-synuclein in both neuroprotection and neurodegenerationAnita Sidhu, Christophe Wersinger, Charbel E-H Moussa, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|June 12, 2003
Diminished expression of constitutive nitric oxide synthases in the kidney of spontaneously hypertensive ratUjendra Kumar, Yangmee Shin, Christophe Wersinger, et al.
Molecular and Cellular Neurosciences|October 11, 2003
Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activityChristophe Wersinger, Delphine Prou, Philippe Vernier, et al.
Pageof 3